Terns Pharmaceuticals, Inc. (TERN)
37.77
+2.43
(+6.88%)
USD |
NASDAQ |
Feb 06, 16:00
37.77
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals SG&A Expense (TTM) : 31.48M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 401.86M |
| Ligand Pharmaceuticals, Inc. | 93.03M |
| ADMA Biologics, Inc. | 96.37M |
| Cidara Therapeutics, Inc. | 28.09M |
| Cogent Biosciences, Inc. | 51.34M |